Alnylam Pharmaceuticals Inc (ALNY)

09:24 AM

Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker - Benzinga

09:24 AM

05:08 AM

Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain institutional flowsJuly 2025 PostEarnings & High Yield Stock Recommendations - newser.com

05:08 AM

04:39 AM

How Alnylam Pharmaceuticals Inc. (DUL) stock reacts to fiscal policies2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com

04:39 AM

01:44 AM

Regression analysis insights on Alnylam Pharmaceuticals Inc. performanceJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com

01:44 AM

Nov 11, 2025

What data driven models say about Alnylam Pharmaceuticals Inc.’s futureWeekly Stock Summary & High Accuracy Investment Entry Signals - newser.com

Nov 11, 2025

Nov 11, 2025

How dovish Fed policy supports Alnylam Pharmaceuticals Inc. (DUL) stockMarket Movement Recap & High Accuracy Swing Entry Alerts - newser.com

Nov 11, 2025

Nov 11, 2025

Wells Fargo Raises Price Target for Alnylam Pharmaceuticals (ALNY) | ALNY Stock News - GuruFocus

Nov 11, 2025

Nov 11, 2025

Is Alnylam Pharmaceuticals Inc. (DUL) stock a fit for income portfoliosJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com

Nov 11, 2025

Nov 11, 2025

Got $5,000? 3 Top Growth Stocks to Buy That Could Double Your Money - Yahoo Finance

Nov 11, 2025

Nov 11, 2025

Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain revenue momentumWeekly Investment Recap & Smart Money Movement Tracker - newser.com

Nov 11, 2025

Nov 10, 2025

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and Insulet (PODD) - The Globe and Mail

Nov 10, 2025

Nov 10, 2025

ALNY: Cardiomyopathy launch accelerates growth as pipeline and new tissue programs drive 2030 vision - TradingView

Nov 10, 2025

Nov 10, 2025

Alnylam at UBS Healthcare: Strategic Insights on Growth and Innovation By Investing.com - Investing.com UK

Nov 10, 2025

Nov 10, 2025

Transcript : Alnylam Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 10 - MarketScreener

Nov 10, 2025

Nov 10, 2025

Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? - 富途牛牛

Nov 10, 2025

Nov 10, 2025

Why global investors buy Alnylam Pharmaceuticals Inc. (DUL) stockJuly 2025 Big Picture & Trade Opportunity Analysis - newser.com

Nov 10, 2025

Nov 09, 2025

Will Alnylam Pharmaceuticals Inc. continue its uptrend2025 Trading Recap & Consistent Growth Stock Picks - newser.com

Nov 09, 2025

Nov 09, 2025

Alnylam (ALNY) Reports Positive Results from HELIOS-B Phase 3 St - GuruFocus

Nov 09, 2025

Nov 09, 2025

Alnylam announces results from post hoc analyses of HELIOS-B Phase 3 study - TipRanks

Nov 09, 2025

Nov 09, 2025

Is Alnylam Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Fed Impact & Low Drawdown Investment Ideas - newser.com

Nov 09, 2025

Nov 09, 2025

Alnylam Pharmaceuticals (ALNY): Assessing Valuation Following New HELIOS-B Data and Upbeat Financial Results - simplywall.st

Nov 09, 2025

Nov 08, 2025

Alnylam Pharmaceuticals Inc says amyloid regression in 22% of vutrisiran-treated patients - MarketScreener

Nov 08, 2025

Nov 08, 2025

Alnylam (NASDAQ: ALNY) HELIOS-B analyses: HR 0.47 in severe CKD for death and CV events - Stock Titan

Nov 08, 2025

Nov 08, 2025

Here's How Much $1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today - Sahm

Nov 08, 2025

Nov 07, 2025

A Closer Look at Alnylam Pharmaceuticals (ALNY) Valuation Following Improved Earnings and Raised Revenue Guidance - Yahoo Finance

Nov 07, 2025

Nov 07, 2025

How Investors May Respond To Alnylam Pharmaceuticals (ALNY) Surging Revenue and Raised 2025 Guidance - simplywall.st

Nov 07, 2025

Nov 07, 2025

Has Alnylam Pharmaceuticals Inc. found a price floorEarnings Beat & AI Enhanced Trading Alerts - newser.com

Nov 07, 2025

Nov 07, 2025

Alnylam Pharmaceuticals Scores Relative Strength Rating Upgrade - Investor's Business Daily

Nov 07, 2025

Nov 06, 2025

Combining machine learning predictions for Alnylam Pharmaceuticals Inc.July 2025 Price Swings & High Accuracy Buy Signal Tips - newser.com

Nov 06, 2025

Nov 06, 2025

Using data filters to optimize entry into Alnylam Pharmaceuticals Inc.July 2025 Momentum & Risk Managed Investment Entry Signals - newser.com

Nov 06, 2025

Nov 06, 2025

How to monitor Alnylam Pharmaceuticals Inc. with trend dashboardsBull Run & Safe Capital Growth Stock Tips - newser.com

Nov 06, 2025

Nov 06, 2025

Published on: 2025-11-09 13:28:49 - newser.com

Nov 06, 2025

Nov 06, 2025

What RSI levels show for Alnylam Pharmaceuticals Inc. (DUL) stockJuly 2025 Intraday Action & Safe Entry Trade Reports - Fundação Cultural do Pará

Nov 06, 2025

Nov 06, 2025

How risky is Alnylam Pharmaceuticals Inc. (DUL) stock compared to peersTrade Performance Summary & Verified High Yield Trade Plans - newser.com

Nov 06, 2025

Nov 06, 2025

Why Alnylam Pharmaceuticals Inc. stock is recommended by analystsWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 06, 2025

Nov 06, 2025

Will Alnylam Pharmaceuticals Inc. stock deliver shareholder valueRate Cut & Weekly Sector Rotation Insights - Fundação Cultural do Pará

Nov 06, 2025

Nov 06, 2025

Is Alnylam Pharmaceuticals Inc. (DUL) stock vulnerable to rate hikesJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com

Nov 06, 2025

Nov 06, 2025

Is Alnylam Pharmaceuticals Inc. (DUL) stock overpriced at current multiplesWeekly Stock Summary & High Accuracy Investment Entry Signals - newser.com

Nov 06, 2025

Nov 05, 2025

How to recover losses in Alnylam Pharmaceuticals Inc. stock2025 Biggest Moves & Short-Term Trading Alerts - newser.com

Nov 05, 2025

Nov 05, 2025

What downside risks could hit Alnylam Pharmaceuticals Inc. (DUL) stockStock Surge & Stock Portfolio Risk Control - newser.com

Nov 05, 2025

Nov 05, 2025

Published on: 2025-11-05 12:16:44 - newser.com

Nov 05, 2025